Revive Therapeutics Announces $10 Million Bought Deal Offering of Units Jan 21 • 5 min read Revive Therapeutics Ltd. announced that is has entered into an agreement with underwriters have agreed to purchase 20,000,000 units at a price of $0.50 per equity unit for gross proceeds to the company of $10,000,000.
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Jan 20 • 4 min read MindMed announced today the start of the first ever clinical trial measuring and evaluating MDMA and LSD used in combination in the human body.
Better Plant Affiliate NeonMind Lists on the Frankfurt Stock Exchange (FSE: 6UF) Jan 19 • 3 min read Better Plant Sciences Inc. announced its partially owned subsidiary NeonMind has common shares now trading on the Frankfurt Stock Exchange under the symbol “6UF“.
Cybin Announces CDN$20 Million Bought Deal Offering Jan 18 • 4 min read Cybin Inc. announced that it has entered into an agreement with Canaccord Genuity Corp. to purchase 8,900,000 units of the company at a price of CDN$2.25 per unit for aggregate gross proceeds of CDN$20,025,000.
Seelos Therapeutics Announces Dosing of the First Patients in a Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Jan 15 • 4 min read Seelos Therapeutics, Inc. announced dosing of the first patients in its registrational Proof of Concept study of SLS-002 (intranasal racemic ketamine) for Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder.